hmds.infohmds.info/.../hmds-annual-user-survey-report-2017.docx · web viewcytogenetics are...

HMDS Annual User Survey Full Report

Requesting TestsThe majority of responders (82%) completed requested forms by hand; however, only 56% stated this was their preferred method.

1. How do you complete a request form for specimens?

Always electronically/online Always handwritten/paper0

10

20

30

40

50

60

70

80

Responses: 83Average: 4.5 (Mostly handwritten/paper)

2. How would you prefer to complete a request form for specimens?

44%

56%

Electronically/onlineHandwritten/paper

Responses: 84

EQMS ID:HD HMDS2476 v1.0 of 28

Majority: 56% (Handwritten/paper)

Sending SpecimensMost responders (88%) were either Satisfied or Very Satisfied with arrangements for sending samples to HMDS. Less than a quarter (22%) experienced difficulties sending samples to HMDS. For those sending samples to HMDS, 62% did not inform HMDS to be expecting any samples.

Responders were asked what problems they faced when sending samples to HMDS. Many responses related to local postage or transport issues causing samples to arrive at HMDS over 24 hours after being taken. Some responses indicated difficulties with knowing where to take samples out of hours, or degradation in samples received over the weekend. There were also responses regarding delaying in receiving confirmation a sample has been received, and well as delays in receiving reports, or insufficient information regarding the diagnosis.

When asked how responders knew that samples had been received by the department the most common answer was that they checked the report status for the sample via the HILIS website. Around 10% stated they called the department whilst 14% said they didn’t know if the sample arrived.

3. How satisfied are you with arrangements to send specimens to HMDS?

Very dissatisfied Very satisfied0

5

10

15

20

25

30

35

40

45

50

Responses: 83Average: 4.4 (Satisfied)


4. Do you ever have problems sending specimens to HMDS?

22%

78%

YesNo

Responses: 83Majority: 78% (No)

5. If applicable, please describe any problems you have encountered when sending samples to HMDS?Can't send samples on a Friday for processing on Saturdays; Delay in confirming receipt of samples; Delays in reports, especially lymphoma lymph node samples; In adequate reports with equivocal and insufficient information about diagnosis; We have no representation in out northwest sector for any HMDS histopathology representation; Not helpful to say that samples need to be interpreted with clinical information so no further tests have been done, if that’s what is needed then it should be sought rather than delaying tests; Delays in transport when using taxi firms for out of hours urgent samples. This is being addressed locally; Having two hospital sites in Hull sometimes leads to delays with samples going from Castle Hill to Hull Royal to then be forwarded on to you. This is a local problem that we are trying to solve, ensuring there is an audit trail of somples moving around.; I know that the lab has had difficulty sending a specimen which arrived after 6pm and there was no clear pathway for reception.; Issues around there not being staff at Leeds when the samples arrive to receive them, usually caused by problems on the M62; Local transport issues rather than from HMDS end.; Lost samples. Sent to HMDS (via AGH) and were lost in transit; Occasionally because we rely on postage doing sampling at the start of the week can sometimes pose a problem but this is rare.; Our only post goes at 15.30 in the Hospital so I sometimes miss it and have to put Trial Samples in the fridge overnight to post the next day.; rely heavily of the specimen shuttles between Mid Yorkshire and Leeds. If I take a specimen on a Friday afternoon, or immediately before a Bank Holiday weekend, I might well regard it as safer, especially if the specimen is small, to send it to our local histopathology lab and rely on them passing it on to you if lymphoma is suspected; samples arriving suboptimally despite being sent by courier same day; Samples received on Fridays


require couriering, no Saturday morning / weekend provision.; Samples sent later half of week usually degraded by time of analysis; sometimes if a bone marrow is requested as an emergency later on in the day special transport has to be arranged to get it to leeds; Sometimes miss the hospital transport and samples > 24 hours old; Sometimes surprised at the length of time it takes for specimen transport to go from York hospital pathology lab to HMDS.; Specimens seem to take a long time to reach HMDS if they are forwarded by the Mid Yorkshire histopathology department, rather than sent directly from theatre on the hospital shuttle service. I would probably send specimens to the local histopathology lab, in formalin, if it was small specimen taken from mid afternoon onwards, or on a Friday afternoon; the problem is with my Trust's post room not sending them first class when asked to; not with HMDS; The problems are from our hospital, not from HMDS; We have had to change courier due to late arrival os samples in Leeds. Samples arriving Saturday morning appear to wait until Monday before they are handled; We have to have post ready by 14:00; this is a failing of our postal department.

6. Do you inform HMDS prior to sending specimens?

Never Always0

5

10

15

20

25

30

35

Responses: 80Average: 2.2 (Rarely)

7. How do you know a specimen has been received by HMDS?Access database; By checking HMDS online; By checking the HMDS secure website; By checking the website; by logging on, or calling; By looking on the website.; By looking up online the next day.; Can see online; Check hilis; Check HILIS; Check in the HMDS website.; Check on HILIS; check on HILIS report in progress; Check on HiLIS system; Check on Hilis the next day or phone if an urgent specimen.; Check on the website that it has been received; check online; Check online to see when booked in


Check receipt on hilis; Check the website; Check the website; Check with the patient details; Checking online; checking the website; Courier; Do not know unless check system an result pending; dont know; DON'T KNOW BUT JUST ASSUME; Don't know!; Either by phoning or checking website; Fax-back form sent with specimen; Hand deliver myself; HAYS DX tracking system; I am unsure if the lab staff inform HMDS, I will inform HMDS if I have a particularly urgent specimen e.g. acute leuk or APML; i assume it gets there; I can check if sample has been logged in to system. If I cannot see it I ring HMDS to chase what has happened; I can see it has been registered on the HMDS website; i can see it when it is registered on the HMDS website – and a specimen has never gone astray when our usual routine shuttle service has been used. I do not trust taxis.; I check online for results very regularly until it appears on screen; usually saying "additional tests outstanding" from then on I check about every 4 days; I check online the HMDS website; I check your website to see its progress.; I do not know; I don't, I await the report; I don't.; I have access to HILIS; I have access to the online portal and can view on there.; I read on the online site; it appears on the results website as incomplete; it shows on the system on HMDS; Liaise with local haematology lab.; Look on HILIS or phone; Look on HMDS website or ring.; Look on website; Looking on line; Pending test notification on website; postage tracking; Receipt of analysis report; Send via tracked / recorded delivery. We would inform HMDS if the sample is urgent / expected late into HMDS. If we submit request forms electronically, could receipt be confirmed via email?; Sent recorded delivery and receive fax receipt confirmation back; Unless it is urgent we are not informed by yourselves; Usually get written report once processed.; Verbal confirmation; Via the Hilis system; We don't; We have to phone to find out; When I log onto the portal and see it has been received; You send back an acknowledgement; its on the system; I would check the website if I thought the results were delayed.


Turnaround Times77% of responders were Satisfied or Very Satisfied with the turnaround times achieved by HMDS.

When asked how we could improve our turnaround times a variety of suggestions were made. The suggestions which were offered multiple times included; o Faster Molecular and Cytogenetic testing, o Authorising reports faster or providing an interim report or estimate until a report

can be given if a delay in expected, o Highlighting urgent samples for faster processing and calling the referring clinician

when the outcome is known, o Better updating when additional studies have been completed. o Unique suggestions covered; o Routine Saturday worko Faster return of samples to referrers o Direct feedback during MDTs

Some responders felt that there was no improvement to the turnaround around times possible.

8. How satisfied are you with our turnaround times to meet your clinical needs?


5

10

15

20

25

30

35

40

45


9. Are there any ways we could improve our turnaround times?AWAITING CYTOGENETICS SOMETIMES TAKES A LONG TIME; BCR-ABL results were delayed recently.; Better/faster real-time reporting of results; Direct feedback during our Haematology MDT; Find that additional tests are not always reported in a timely manner eg


cytogenetics are stated as outstanding and then results of these are either never resulted or take months to be resulted.; If a specimen is passed back to histopathology in Mid Yorkshire, when an alternative diagnosis to a haematological malignancy has been achieved, it seems to take a long time for the specimen to arrive back in Mid Yorkshire; Issue repport earlier then current time sclale, if feasible.; Maybe an estimate of how long results will be available be helpful. And knowing who’s reporting can help direct clinicians in certains; Molecular studies often seem to cause delays - could this be improved?; More robust system for highlighting urgent samples as telephone calls to reception do not seem to follow through to lab. Routine sample turn around time is very good; No specific recommendation can be made as already serving an excellent service; Not is we want such useful and integrated reports. There does seem a delay in cytogenetics for AML samples.; Not really. In my experience if a sample is not ready, there is usually a good reason and someone is always prepared to help me if I am stuck for a diagnosis; Often I have to phone to chase a report. It seems that if additional testing has been performed the processes in place to update the report or provide an updated diagnosis are less than robust and the phone call is used for this purpose instead.; Often need to chase final approval for trial samples; Perhaps an urgent turnaround service if requested; Probably not, but when a specimen takes a long time to be reported (e.g. some T cell lymphomas), some sort of interim update might help us to deal with patient anxiety; routine Saturday working would be good; Sometimes bcr-abl and Jak2 results can take a few weeks; Speed up referral to us with cases of non-haemopoetic neoplasms as this can be very slow and if there is no duplicate biopsy in house is potentially detrimental to patient care; There is sometimes a delay between the report appearing on the web site and it being authorised; Thes questions are not applicable to my Research needs.; To call on the phone if this is a new acute leukaemia; UNLIKELY AS VERY GOOD; Updates o diagnosis are not communicated have to wait weeks for further studies to samples in some cases.


Out of hours serviceThe question regarding Out of hours access was compulsory; of the 91 responses only 24% stated that they had used the out-of-hour services. All those who responded that they had used the service had neutral or positive experiences with the service, with 60% stating they were Very Satisfied. There were no suggestions for improvements to the service, with one user commenting that it was “very easy to speak to one of you to get advice about an evening or weekend sample”.

10. Have you used our out of hours service?

24%

76%

YesNo

Responses: 91 (Required) Majority: 76% (No)

11. How satisfied are you with our out of hours service?


2

4

6

8

10

12

14

Responses: 22 Average: 4.5 (Satisfied)

12. Are there any ways we could improve our out of hours service?Current level of input is adequate for local requirements; It is always easy to speak to one of you to get advice about an evening or weekend sample and if it will have clinical impact


by getting a result out of hours. You tend not to be too grumpy out of hours!; Not that I am aware of. Thanks


Report DetailsThe majority (85%) of responders were Satisfied or Very Satisfied with the overall report provided by HMDS. The percentage of users who felt that the clinical interpretations within the report were helpful and easy to understand was 82%, with the average at fairly helpful and easy to understand.

Most responders were not aware (70%) or used (79%) the link to the Haematological Malignancy Research Network that is linked to on the HMDS reports.

When asked what further information could be provided on the reports suggestions included; o Faster updating of cytogenetic results For AML pts it would be useful to include FLT3 and NPM1 in the molecular even if they are wild type because of the prognostic significance.I would help cascading further investigations particularly for PRV?ET, if jak2 negative in suspected PRV to do Exon 12 mutation without further sample and request, similarly in suspected ET to do MPL mutation if JAK2 negative.If a node is reported as “reactive”, and particularly when there are multiple nodes enlarged, additional advice about likely underlying cause would be very helpful and is sometimes given when the reporting histopathologist is “pushed”, but isn’t always volunteered. If granulomatous inflammation is seen and a specimen hasn’t already been recorded as sent to microbiology for culture, could more effort be made of a portion of the fresh tissue (if such was sent) to be passed on for culture?recent lymph node biopsy was reported, to my surprise, as showing granulomatous inflammation and TB suggested. No mention of caseating necrosis was made and clinically I am more suspicious of sarcoidosis. If TB is going to be suggested as the most likely diagnosis, could you please say why not sarcoid?Reports are great. Though some of the micro array results could do with correlation with risk.ver scanty if non-haemopetico More graphics for training purposeso Inclusion of the referring laboratory reference number to aid reconciliationo Meaningful interpretations of newer testso Interpretation of significance of HTS on myeloid caseso Guidance on prognostic significance of FISH results for myeloma caseso Included negative results for crucial testso Clearer layout of the report to aid interpretation o Opportunity to discuss report with reporting clinician, including information on

internal discussions regarding urgent sampleso More detailed morphological details

Then I don’t really understand the points below enough to simplify themEQMS ID:HD HMDS2476 v1.0

of 28

13. How satisfied are you with the overall report provided?


5

10

15

20

25

30

35

40

45


14. Are the clinical interpretations helpful and easy to understand?

Not at all Extremely0

5

10

15

20

25

30

35

40

45

Responses: 87Average: 4.1 (Fairly helpful and easy to understand)


15. Are you aware that the HMDS report now links to HMRN (Haematological Malignancy Research Network) prognostic data?

30%

70%

YesNo


16. Do you use the link to HMRN described above?

21%

79%

YesNo



17. Would you like more information on the reports, if so what information?At the moment we are unable to receive reports by email and would suggest that Leeds devices some sort of IT link via which all requests and reports could be sent i.e ICE or other lab to lab interface. This would also avoid transcription errors when reporting into our LIM’s system.; Cytogenetic results should be added when available. When a diagnosis has been made on clinical grounds at MDT the HMDS report should be updated to include this.; For AML pts it would be useful to include FLT3 and NPM1 in the molecular even if they are wild type because of the prognostic significance.; Further graphics - useful for teaching registrars; I don't feel they are easily readable. I had to contact trial office to explain how to interpret results. It would be good for reports to state MRD positive/MRD negative; I personally find the lay out of the histology generated reports a little odd, with a diagnosis and comment at the top and the body of the report beneath.; I think there is enough info and anything that needs more clarification we bring to MDT; I would help cascading further investigations particularly for PRV?ET, if jak2 negative in suspected PRV to do Exon 12 mutation without further sample and request, similarly in suspected ET to do MPL mutation if JAK2 negative.; If a node is reported as “reactive”, and particularly when there are multiple nodes enlarged, additional advice about likely underlying cause would be very helpful and is sometimes given when the reporting histopathologist is “pushed”, but isn’t always volunteered. If granulomatous inflammation is seen and a specimen hasn’t already been recorded as sent to microbiology for culture, could more effort be made of a portion of the fresh tissue (if such was sent) to be passed on for culture?; Interpretation of significance of high throughput sequencing on myeloid cases and guidance on the prognostic significance of the FISH results in myeloma cases.; Maybe the opportunity to discuss the case with the reporting pathologist?; More detailed morphological description.; More details of microscopic features, leading to the diagnosis and not just a list of immunostains/molecular tests.; NO; No; No; No, there is enough for my research needs.; Not currently, but maybe at a future date; NOT PARTICULARLY; Please include our laboratory reference number on the report, this helps us reconcile the report within our LIMS.; recent lymph node biopsy was reported, to my surprise, as showing granulomatous inflammation and TB suggested. No mention of caseating necrosis was made and clinically I am more suspicious of sarcoidosis. If TB is going to be suggested as the most likely diagnosis, could you please say why not sarcoid?; Reports are great. Though some of the micro array results could do with correlation with risk.; Some important negatives would be useful to confirm the sample has been tested for this, and found negative, rather than the test may have been omitted would be useful.; The newer tests need meaningful clinical interpretations; ver scanty if non-haemopetic; Whom results have been discussed with when urgent and the outcome of discussion; A referring laboratory reference number would be useful as an extra identifier.


Contacting the laboratoryThe preferred method to contact the department is via phone (63%). Most responders (84%) stated that they found it Easy or Very Easy to contact the department with only 6% experiencing any problems. Nearly all responders (93%) stated that they were Satisfied or Very Satisfied with the assistance provided once they had contacted the department.

When asked what problems were encountered when contacting the department, responses mainly stated that it was difficult to know who to relevant individual to speak to was, and that it was easy to contact the department but not always the correct person. One individual could not find the number for the department on the HILIS Report website, and others received no response via email or through the dedicated messaging service.

18. How do you prefer to contact HMDS?

34%

63%

3%

EmailPhoneOther

Responses: 86Majority: 63% (Phone)


19. How easy it is to contact HMDS?

Very difficult Very easy0

5

10

15

20

25

30

35

40

45

Responses: 85Average: 4.3 (Easy)

20. Do you have problems contacting HMDS?6%

94%

YesNo


21. If applicable, please describe any problems you have encountered when contacting HMDS?DONT ALWAYS KNOW THE CORRECT NUMBER TO SPEAK TO THE RELEVANT PERSON; Emails sent through the dedicated messaging link on HMDS website are rarely answered by consultants; finding the number at times - not on results site; Getting through is rarely a problem but clinical staff are not always available; I always ring as I never get response back


via e-mail; I have never had to contact HMDS; I haven't contacted HMDS directly. If there is a problem I discuss this with the trial who has requested a sample to be sent; I wasn't aware I could email. Have always tried to ring and then never sure who best to speak to. Histology reports come with 2, 3 or even more names on them (reported by? authorised by?), difficult for me to determine who is overall responsible for the report issued and thus who best to approach.; N/A; None; None; none; None; None. Vinette is wonderful :); Sometimes it is very difficult to find the correct person required and can be difficult to get put through

22. When you do contact us, how satisfied are you with the assistance provided?


10

20

30

40

50

60



HILIS MessagingFew responders (17%) knew about the presence of the dedicated messaging service on HILIS, with only 40% of those who knew about the service using it. There were multiple reasons provided for why individuals weren’t using, or what was preventing them from using, the messaging service; o Not knowing it existedo No response receivedo No alert given when a response is sento No requirement to use ito Easier to phone

23. Do you know about the dedicated messaging service on HILIS?

17%

83%

YesNo


24. Do you use the dedicated messaging service on HILIS?

40%

60%

YesNo


Responses: 15 Majority: 60% (No)


25. Are there any reasons you don't use, or reasons that are stopping you from using HILIS messaging service more often?Did not know about HILIS as i mainly just check reports; Didn’t know about and have never had to use it; Don't always get answered. Requires me to log in to check for an answer. ? could HILIS email me when a response is posted?; Easier to phone; I don't usually get a response or reply; I HAVE NOT NEEDED TO USE IT AS YET; I have used it once or twice, but didn't receive any reply, so can't say I was very happy.; NO; No; Prefer telephone for discussion; Used it once and got no reply.

26. What reasons are stopping you from using the HILIS messaging service more often, or at all?Clinical risk; Happy with contact route; I don’t send specimens just look for results; I usually don't get a reply or response.; Lack of acknowledgement or response from the reporting pathologist.; Not required so far.


Testing RepertoireNearly all (99%) of responders stated that the current testing repertoire was appropriate for their needs. The responder, who stated that the current testing repertoire was not appropriate to their needs, stated that they felt it would be easier if one centre completed all testing as currently cytogenetic testing is completed at another site which incurs additional transport costs. Other suggestions for improvements included P53 mutation status for CLL cases, and improved reports.

Approximately three-quarters (78%) of responders felt that HMDS should develop guidance on the appropriateness of specific investigations in particular clinical settings. Some suggestions regarding providing additional prognostic information were given though concern was raised regarding the relevance if HMDS did not have access to sufficient clinical data for the patient. The suggestions included; o Myeloma, CLL and lymphoma - more specific interpretationo Molecular markers for AML samples (NPM1, FLIT 3 etc)o Advice on possible underlying causes for significant, persistent reactive

lymphadenopathy (not single small nodes)o Initiating culture for TB or PCR for surprise diagnosis of granulomatous inflammation

(if tissue is still available)

27. Is the current test repertoire appropriate for your needs?

99%

1%

YesNo

Responses: 80Majority: 99% (Yes)

28. Are there any tests that could be added to improve our repertoire?Currently all cytogenetics are sent to Christie would it not be easier for one centre to provide all the required test for HMDS. This causes duplication in terms of costs for transporting samples to the correct places; Keep up to date with needs of clinical trials as


new tests became standard; no; no; NO; No; None immediately spring to mind.; not aware; P53 mutation status CLL; The reports should be better formatted and logical.

29. Should HMDS develop guidance on the appropriateness of specific investigations in particular clinical settings?

78%

22%

YesNo

Responses: 73Majority: 78% (Yes)

30. Are there areas where additional prognostic information would be useful?As above, advice on possible underlying causes for significant, persistent reactive lymphadenopathy (not single small nodes) and initiating culture for TB or PCR if we have a surprise diagnosis of granulomatous inflammation and if tissue is still available; molecular markers for AML samples (NPM1, FLIT 3 etc); Myeloma, CLL and lymphoma - could do with more specific interpretation; N/A; NOT SURE; perhaps - but hmds will not have access to clinical data for most patients to be able to give prognostic score feedback etc


Participation in MDTsMost responders stated that they found HMDS’s contributions to MDT meetings Fairly or Extremely useful. This increased from 68% to 74% when responses indicating that HMDS was not involved with their MDT meetings were removed.

The suggestions offered to improve HMDS participation in MDTs covered contributing more to the meetings than only the report, knowing about the status of outstanding results and presenting unusual cases.

31. How useful do you find the HMDS contribution to MDT meetings?


5

10

15

20

25

30

35

40

Responses: 66Average: 4.1 (Useful)


5

10

15

20

25

30

35

40

Responses: 59


Average: 4.3 (Useful)(Adjusted to remove those that stated HMDS aren’t involved in MDT Meetings)32. How do you think the HMDS contribution to MDT meetings could be further improved?be more prepared when asked about the status of specimens and chase outstanding results; Cannot comment as I have not attended an MDT meeting for a long time now.; COULDNT BE IMPROVED; hmds are not linked to our mdt; HMDS is not part of the Head & Neck MDT directly, so this question is not really relevant to me; HMDS should actively contribute to the meeting and not simply be voice with a report.; I am unsure if there is direct involvement of the HMDS in our MDT beyond the report.; I found the dialogue better when they actually attended our MDT, but appreciate that is too time consuming.; N/A; NA; No; no; No experience of HMDS input into MDTs.; not applicable, as I am a member of the Head & Neck MDT, not haematology.; Personaly I would like to see pictures of interesting/ unusual cases. I feel I am loosing my laboratory skills; very satisfied; We currently only use HMDS for clinical trial results


Overall ServiceOverall, 97% of responders were either Satisfied or Very Satisfied with the service provided by HMDS, with 69% stating they were Very Satisfied.

Further comments included; o Guidelines/guidance to avoid unnecessary testing especially for cutaneous lymphoma

referralso Requests for faster uploading of cytogenetic resultso Improved report layout to aid with transcribing results to local systems, including

requests for a direct interface with local systems o Requests to show atypical common presentations during MDTs to aid training o Requests to ensure that reports are returned to the individual requesting the test as

well as the individual referring the patient

There were several comments praising the service provided including “HMDS is a fantastic service and very easy to use. It is a particular advantage being able to access the reports directly. Thank you!” and “I have contacted the HMDS service a number of times for various reasons and always find the staff very helpful and informative. Thank You .”

33. How satisfied are you with the overall service provided by HMDS?


10

20

30

40

50

60

70

Responses: 89Average: 4.7 (Very Satisfied)


Further Comments34. Do you have any other comments you would like to record?As a DGH histopathologist, we receive a not insignificant number of skin biopsies from dermatologists requesting HMDS input/marker studies, which I suspect is far out of proportion with the number of cutaneous lymphoma patients out there! Perhaps some guidance to dermatologists from HMDS as to what should be investigated for CTCL would reduce the work/costs that they generate for pathology services regionally.; HMDS is a fantastic service and very easy to use. It is a particular advantage being able to access the reports directly. Thank you!; I do have an issue with where the reports are sent to when it is a referred sample from histopathology. It seems the report is sent to the referring histopathologist rather than going to the person who requested the test in the first place. I am sure this must lead to some reports never reaching their rightful owner. I know it would mean some detective work but personally I think it is the clinician requesting the test who should get the report, not the histopathologist asking for a HMDS review.; I have contacted the HMDS service a number of times for various reasons and always find the staff very helpful and informative. thank you; I have very limited use - only for Clinical Trial purposes.; I only use HMDS as a read only basis - to seek clarification on a diagnosis for coding purposes.; Is it possible show one or two slides per MDT only rare or atypical common presentation esp. trephine biopsy for training please.; Leeds really needs to develop an IT system that will support transfer of data from lab to lab to avoid the use of paper reports, or emails. This must be the obvious way to ensure that results are faithfully tranfered from one lab to another and is already operational in other parts of the country; no; NO; Occasionally sample results are sent to the wrong hospital; Regarding questions 1 and 2, we have set up a Word template into which we can automatically copy and paste information from our LIMS (Telepath) before printing a paper request.; We transcribe your reports into our LIMS. With incremental reports, it is not easy to pick out what is the new component so that we can add just this.; Out LIMS (Telepath) does not recognise superscripting, so with the loss of this formatting, some of the information becomes difficult to interpret; Thanks for very useful services you provide.; The HMDS report is pasted into local systems so that all clinicians have easy access, but the boxed lay-out and range of font types makes this difficult to do.; There are sometimes significant delays in getting the cytogenetics reports onto Hilis which I appreciate is more of an IT issue. It would be extremely helpful to have those in a timely fashion.; wrt guidance - guidelines to help reduce excessive / unnecessary testing with evidence / stats to support them would be very useful in reducing inappropriate tests and our costs


About YouAll responders were asked to state their position and location for the survey. There were 11 different options for position provided, with an additional Other option. The location was free text, with the answers being collated into regional areas.

A third of responses were from Consultants (36%), followed by 22% from Nurse Specialists, and 14% from Administrative Staff. Over half the responses were received from individuals based within Yorkshire and the Humber (54%) region, with the North West providing the second largest number of responses at 30%.

9 individuals left sufficient details for further contact.

35. Which of the following best describes your position?

Junior Doctor1%

Lab Staff3% Lab Manager

4%Doctor

6%

Nurse7%

Other7%

Admin Staff14%

Nurse Specialist22%

Consultant36%

Responses: 90Top Three Staff Groups: 36% Consultant, 22% Nurse Specialist, 14% Admin Staff


36. Which region are you based in?

London1%

Scotland1%

West Midlands1%

Wales2% South East

3%East Midlands

7%

North West30%

Yorkshire and the Humber

54%

Responses: 87Top Three Regions: 54% Yorkshire and the Humber, 30% North West, 7% East Midlands

37. If you would like to be contacted to discuss any comments further, please provide your name and contact email below.

9 (9.8%) left sufficient details to be contacted.


hmds.infohmds.info/.../hmds-annual-user-survey-report-2017.docx · web viewcytogenetics are...

Documents